JP2001524353A - 複数の区画を有する医療用溶液用容器 - Google Patents
複数の区画を有する医療用溶液用容器Info
- Publication number
- JP2001524353A JP2001524353A JP2000522874A JP2000522874A JP2001524353A JP 2001524353 A JP2001524353 A JP 2001524353A JP 2000522874 A JP2000522874 A JP 2000522874A JP 2000522874 A JP2000522874 A JP 2000522874A JP 2001524353 A JP2001524353 A JP 2001524353A
- Authority
- JP
- Japan
- Prior art keywords
- compartment
- concentration
- glucose
- calcium
- contents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008155 medical solution Substances 0.000 title claims abstract description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 75
- 239000008103 glucose Substances 0.000 claims abstract description 74
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 62
- 239000011575 calcium Substances 0.000 claims abstract description 62
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 62
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 28
- 239000000243 solution Substances 0.000 claims abstract description 23
- 239000000385 dialysis solution Substances 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 16
- 238000000502 dialysis Methods 0.000 claims abstract description 13
- 238000003860 storage Methods 0.000 claims abstract description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 18
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 4
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000003186 pharmaceutical solution Substances 0.000 claims 2
- -1 5 mM calcium Chemical compound 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 22
- 239000011780 sodium chloride Substances 0.000 abstract description 11
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001540 sodium lactate Substances 0.000 abstract description 4
- 229940005581 sodium lactate Drugs 0.000 abstract description 4
- 235000011088 sodium lactate Nutrition 0.000 abstract description 4
- 238000000108 ultra-filtration Methods 0.000 abstract description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 18
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 12
- 210000004303 peritoneum Anatomy 0.000 description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 7
- 229910001628 calcium chloride Inorganic materials 0.000 description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940001447 lactate Drugs 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000013038 Hypocalcemia Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000000705 hypocalcaemia Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000037147 Hypercalcaemia Diseases 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000148 hypercalcaemia Effects 0.000 description 2
- 208000030915 hypercalcemia disease Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 208000000187 Abnormal Reflex Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000009460 calcium influx Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 206010020745 hyperreflexia Diseases 0.000 description 1
- 230000035859 hyperreflexia Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704386A SE512349C2 (sv) | 1997-11-28 | 1997-11-28 | Flerkammarbehållare för medicinsk lösning, förfarnde för beredning av medicinsk lösning för peritonealdialys samt användning av sådan behållare vid beredning av medicinsk lösning |
| SE9704386-3 | 1997-11-28 | ||
| PCT/SE1998/002146 WO1999027885A1 (en) | 1997-11-28 | 1998-11-27 | Multiple compartment container for medical solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001524353A true JP2001524353A (ja) | 2001-12-04 |
Family
ID=20409165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000522874A Pending JP2001524353A (ja) | 1997-11-28 | 1998-11-27 | 複数の区画を有する医療用溶液用容器 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1035823A1 (sv) |
| JP (1) | JP2001524353A (sv) |
| KR (1) | KR20010032191A (sv) |
| CN (1) | CN1280481A (sv) |
| AU (1) | AU742793B2 (sv) |
| BR (1) | BR9815055A (sv) |
| CA (1) | CA2311903A1 (sv) |
| SE (1) | SE512349C2 (sv) |
| WO (1) | WO1999027885A1 (sv) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017038959A1 (ja) * | 2015-09-03 | 2017-03-09 | 太 宮崎 | キット製剤及び用量調整方法 |
| WO2020036231A1 (ja) | 2018-08-17 | 2020-02-20 | レジメンキット株式会社 | 用量調整が必要なキット製剤の薬剤管理方法 |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69527923T2 (de) | 1994-07-01 | 2003-04-24 | Baxter Int | Biochemisch isotone peritonealdialyselösungen |
| CA2307162C (en) * | 1997-10-27 | 2006-03-21 | Otsuka Pharmaceutical Factory, Inc. | Packaged ophthalmic perfusate and cleaning fluid bag |
| DE19912850B4 (de) † | 1999-03-22 | 2005-04-07 | Fresenius Medical Care Deutschland Gmbh | Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung |
| SE9903331D0 (sv) | 1999-09-16 | 1999-09-16 | Gambro Lundia Ab | Method and apparatus for sterilising a heat sensitive fluid |
| EP1165148A1 (en) | 1999-03-30 | 2002-01-02 | Gambro Lundia AB | Method and apparatus for sterilising a heat sensitive fluid |
| US7122210B2 (en) † | 2002-01-11 | 2006-10-17 | Baxter International Inc. | Bicarbonate-based solutions for dialysis therapies |
| SE524531C2 (sv) * | 2002-12-10 | 2004-08-24 | Gambro Lundia Ab | Metod för att framställa en medicinsk lösning för peritonealdialys där en lösning innehållandes ett eller flera acetylerade eller deacetylerade aminosocker värme- eller strålningssteriliseras med bestämda pH-värden och med bestämda viktsprocent för att undvika att cytotoxiska produkter bildas |
| AU2003283940B2 (en) * | 2002-12-10 | 2008-09-11 | Gambro Lundia Ab | A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| EP1569596B1 (en) * | 2002-12-10 | 2008-08-06 | Gambro Lundia AB | A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| SE524530C2 (sv) * | 2002-12-10 | 2004-08-24 | Gambro Lundia Ab | Metod för att framställa en medicinsk lösning för peritonealdialys där en lösning innehållandes ett eller flera acetylerade eller deacetylerade aminosocker värme- eller strålningssteriliseras med bestämda pH-värden och med bestämda viktsprocent för att undvika att cytotoxiska produkter bildas. |
| SE0301577L (sv) | 2003-05-28 | 2004-11-29 | Gambro Lundia Ab | Lösning med låg natriumhalt |
| US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
| DE102010039489A1 (de) * | 2010-08-18 | 2012-02-23 | Fresenius Medical Care Deutschland Gmbh | Konzentrat |
| US11077238B2 (en) | 2013-06-07 | 2021-08-03 | Allena Pharmaceuticals, Inc. | Compositions, methods, and devices for dialysis |
| DK178893B1 (en) * | 2015-07-05 | 2017-05-01 | Dorte Dyrsborg | Intravenous Bag |
| DE102018103937A1 (de) * | 2018-02-21 | 2019-08-22 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung enthaltend Dialyselösung oder Dialyselösungskonzentrat |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH686778A5 (fr) * | 1987-05-29 | 1996-06-28 | Vifor Medical Ag | Récipient destiné au stockage séparé de composés actifs et à leur mélange subséquent. |
| EP0442406B1 (en) * | 1990-02-14 | 1995-07-26 | Material Engineering Technology Laboratory, Inc. | Filled and sealed, self-contained mixing container |
-
1997
- 1997-11-28 SE SE9704386A patent/SE512349C2/sv not_active IP Right Cessation
-
1998
- 1998-11-27 KR KR1020007005381A patent/KR20010032191A/ko not_active Application Discontinuation
- 1998-11-27 JP JP2000522874A patent/JP2001524353A/ja active Pending
- 1998-11-27 WO PCT/SE1998/002146 patent/WO1999027885A1/en not_active Application Discontinuation
- 1998-11-27 EP EP98959333A patent/EP1035823A1/en not_active Withdrawn
- 1998-11-27 AU AU15153/99A patent/AU742793B2/en not_active Ceased
- 1998-11-27 CN CN98811625A patent/CN1280481A/zh active Pending
- 1998-11-27 BR BR9815055-3A patent/BR9815055A/pt unknown
- 1998-11-27 CA CA002311903A patent/CA2311903A1/en not_active Abandoned
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017038959A1 (ja) * | 2015-09-03 | 2017-03-09 | 太 宮崎 | キット製剤及び用量調整方法 |
| JPWO2017038959A1 (ja) * | 2015-09-03 | 2018-06-28 | 太 宮崎 | キット製剤及び用量調整方法 |
| US11554080B2 (en) | 2015-09-03 | 2023-01-17 | Futoshi Miyazaki | Kit preparation and dose adjustment method |
| WO2020036231A1 (ja) | 2018-08-17 | 2020-02-20 | レジメンキット株式会社 | 用量調整が必要なキット製剤の薬剤管理方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010032191A (ko) | 2001-04-16 |
| WO1999027885A1 (en) | 1999-06-10 |
| AU1515399A (en) | 1999-06-16 |
| BR9815055A (pt) | 2002-04-30 |
| SE512349C2 (sv) | 2000-03-06 |
| SE9704386D0 (sv) | 1997-11-28 |
| SE9704386L (sv) | 1999-05-29 |
| EP1035823A1 (en) | 2000-09-20 |
| AU742793B2 (en) | 2002-01-10 |
| CN1280481A (zh) | 2001-01-17 |
| CA2311903A1 (en) | 1999-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001524353A (ja) | 複数の区画を有する医療用溶液用容器 | |
| AU779950B2 (en) | Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy | |
| TWI326597B (en) | Bicarbonate-based solutions for dialysis therapies | |
| JP5947334B2 (ja) | イコデキストリンを含有する生体適合性透析液 | |
| JP5690040B2 (ja) | 重炭酸塩ベースの腹膜透析溶液 | |
| US8158157B2 (en) | Multi-part substitution infusion fluids and matching anticoagulants | |
| JP2009131669A (ja) | 単一容器中にある重炭酸塩ベースの溶液 | |
| JP2009051850A (ja) | Ｌ−カルノシンを含む腎不全の処置用の組成物 | |
| JP4135849B2 (ja) | 溶液、とくに、血液透析または腹膜透析のための溶液およびその調製方法 | |
| JPH08131542A (ja) | 腹膜透析液調製用溶液セット | |
| MXPA00005012A (en) | Multiple compartment container for medical solution | |
| AU2008201009B2 (en) | Bicarbonate-based solutions for dialysis therapies |